Wu Ting, Xiao Fei, Li Wenli
Key Laboratory of Marine Drugs, Ministry of Education of China, School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003 China.
Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology, Qingdao, 266237 China.
Mar Life Sci Technol. 2020 Oct 14;3(1):62-68. doi: 10.1007/s42995-020-00068-6. eCollection 2021 Feb.
Marine microorganisms have proven to be a rich source of natural products with unique structures and novel activities, due to their special living conditions. Macrolactins (MLNs), mostly produced by marine-derived microorganisms, are a group of 24-membered lactone natural products, which exhibit potent antibacterial, antifungal, antiviral, anticancer, anti-inflammatory, anti-angiogenic and other activities. Their extensive biological activities make them potential compounds for drug development. MLNs are biosynthesized via a type I polyketide synthase (PKS) pathway with different tailoring steps, such as epoxidation, glycosylation and acylation. These modification steps provide opportunities to diversify their structures by combinatorial biosynthesis strategies. This review mainly focuses on the newly discovered MLNs in the past five years, including their biological activities and relevant biosynthetic studies.
由于其特殊的生存条件,海洋微生物已被证明是具有独特结构和新颖活性的天然产物的丰富来源。大环内酯类化合物(Macrolactins,MLNs)主要由海洋来源的微生物产生,是一类24元内酯天然产物,具有强大的抗菌、抗真菌、抗病毒、抗癌、抗炎、抗血管生成等活性。它们广泛的生物活性使其成为药物开发的潜在化合物。MLNs通过I型聚酮合酶(PKS)途径进行生物合成,并伴有不同的修饰步骤,如环氧化、糖基化和酰化。这些修饰步骤为通过组合生物合成策略使它们的结构多样化提供了机会。本综述主要关注过去五年新发现的MLNs,包括它们的生物活性和相关的生物合成研究。